Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model.
Stefano JT, Pereira IV, Torres MM, Bida PM, Coelho AM, Xerfan MP, Cogliati B, Barbeiro DF, Mazo DF, Kubrusly MS, D'Albuquerque LA, Souza HP, Carrilho FJ, Oliveira CP.
Stefano JT, et al. Among authors: mazo df.
Braz J Med Biol Res. 2015 May;48(5):408-14. doi: 10.1590/1414-431X20143962. Epub 2015 Feb 24.
Braz J Med Biol Res. 2015.
PMID: 25714891
Free PMC article.